Common use of Transactions with Principals Clause in Contracts

Transactions with Principals. The Company may take the following actions without the prior consent of a Majority in Interest provided that such actions are approved by a majority of the Compensation Committee of the Board of Directors: • Provide compensation to employees in excess of $100,000 per year, including increases in compensation in a manner that the Compensation Committee of the Board determines to be reasonable and in the best interests of the Company. • Hire additional employees to fill newly created positions and/or to fill vacancies created by the termination or resignation of any employee on terms, including the payment of compensation in excess of $100,000 per year, that the Board of Directors determines are reasonable and in the best interests of the Company. • Make adjustments to the compensation payable to the Company’s scientific founder and Chairman of the Company’s Scientific Advisory Board in a manner that the Board determines to be reasonable and in the best interest of the Company. Schedule 9(w) Lockup Providers Xxx Xxxxxxxx-Mood Xxxxxxxx xx Xxxxx Xxxx X. XxXxxxxxx Xxxx X. XxXxxxx Xxxxxxx Xxxxxxx Xxxxxxxx XxXxxxx Schedule 12(a) Excepted Issuances There are 1,670 shares of Series D Convertible Preferred Stock currently outstanding, which are convertible into shares of Common Stock of the Company at a current conversion price of $0.082. Additionally, four employees were granted stock options in the amounts and at the exercise prices set forth below: Options Exercise Price Effective Date Vesting Period (Years) 25,000 $ 0.080 9/8/2009 3 70,000 $ 0.090 2/8/2010 3 30,000 $ 0.090 2/8/2010 3 5,000 $ 0.090 11/16/2009 3 Schedule 00 Xxxxxx Xxxxxxx Xxxxxx Xxxxxxx Outstanding Principal Amount Xxxx Xxxxxxx $350,000

Transactions with Principals. The Company may take the following actions without the prior consent of a Majority in Interest provided that such actions are approved by a majority of the Compensation Committee of the Board of Directors: • Provide compensation to employees in excess of $100,000 per year, including increases in compensation in a manner that the Compensation Committee of the Board determines to be reasonable and in the best interests of the Company. • Hire additional employees to fill newly created positions and/or to fill vacancies created by the termination or resignation of any employee on terms, including the payment of compensation in excess of $100,000 per year, that the Board of Directors determines are reasonable and in the best interests of the Company. • Make adjustments to the compensation payable to the Company’s scientific founder and Chairman of the Company’s Scientific Advisory Board in a manner that the Board determines to be reasonable and in the best interest of the Company. Schedule 9(w9(y) Lockup Providers Xxx Xxxxxxxx-Mood Xxxxxxxx xx Xxxxx Xxxx X. XxXxxxxxx Xxxx X. XxXxxxx Xxxxxxx Xxxxxxx Xxxxxxxx XxXxxxx Schedule 12(a) Excepted Issuances There are 1,670 shares of Series D Convertible Preferred Stock currently outstanding, which are convertible into shares of Common Stock of the Company at a current conversion price of $0.082. Additionally, four employees were granted stock options in the amounts and at the exercise prices set forth below: Options Exercise Price Effective Date Vesting Period (Years) 25,000 $ 0.080 9/8/2009 3 70,000 $ 0.090 2/8/2010 3 30,000 $ 0.090 2/8/2010 3 5,000 $ 0.090 11/16/2009 3 Schedule 00 Xxxxxx Xxxxxxx Xxxxxx Xxxxxxx Outstanding Principal Amount Xxxx Xxxxxxx $$ 350,000

Transactions with Principals. The Company may take the following actions without the prior consent of a Majority in Interest provided that such actions are approved by a majority of the Compensation Committee of the Board of Directors: • Provide compensation to employees in excess of $100,000 per year, including increases in compensation in a manner that the Compensation Committee of the Board determines to be reasonable and in the best interests of the Company. • Hire additional employees to fill newly created positions and/or to fill vacancies created by the termination or resignation of any employee on terms, including the payment of compensation in excess of $100,000 per year, that the Board of Directors determines are reasonable and in the best interests of the Company. • Make adjustments to the compensation payable to the Company’s scientific founder and Chairman of the Company’s Scientific Advisory Board in a manner that the Board determines to be reasonable and in the best interest of the Company. Schedule 9(w) Lockup Providers Xxx Xxxxxxxx-Mood Xxxxxxxx xx Xxxxx Xxxx X. XxXxxxxxx Xxxx X. XxXxxxx Xxxxxxx Xxxxxxx Xxxxxxxx XxXxxxx Schedule 12(a) Excepted Issuances There are 1,670 shares of Series D Convertible Preferred Stock currently outstanding, which are convertible into shares of Common Stock of the Company at a current conversion price of $0.082. Additionally, four employees were granted stock options in the amounts and at the exercise prices set forth below: Options Exercise Price Effective Date Vesting Period (Years) 25,000 $ 0.080 9/8/2009 3 70,000 $ 0.090 2/8/2010 3 30,000 $ 0.090 2/8/2010 3 5,000 $ 0.090 11/16/2009 3 Schedule 00 Xxxxxx Xxxxxxx Xxxxxx Xxxxxxx Outstanding Principal Amount Xxxx Xxxxxxx $$ 350,000